FDA says decongestant in many cold medicines doesn’t work. So what does?
- U.S. Officials are moving to phase out phenylephrine, the leading decongestant in many over-the-counter medicines, as it does not relieve nasal congestion.
- The Food and Drug Administration proposed revoking phenylephrine's use in pills and liquid solutions, which may lead to drugmakers reformulating products.
- Experts found that phenylephrine was no more effective than a placebo for clearing nasal passageways, impacting about $1.8 billion in annual sales.
- Doctors believe Americans will benefit from removing phenylephrine, stating that choosing a medication that does not work is not a real choice.
Insights by Ground AI
Does this summary seem wrong?
Coverage Details
Total News Sources0
Leaning Left27Leaning Right3Center25Last UpdatedBias Distribution49% Left
Bias Distribution
- 49% of the sources lean Left
49% Left
L 49%
C 45%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
